![](/img/cover-not-exists.png)
647 Chemokine Receptor Antagonist CCX282-B (Traficet-En™) Maintained Remission of Crohn's Disease in PROTECT-1 Study
Satish Keshav, Daniel Johnson, Thomas Schall, Pirow BekkerVolume:
138
Year:
2010
Language:
english
DOI:
10.1016/s0016-5085(10)60392-7
File:
PDF, 76 KB
english, 2010